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We studied the usefulness of serum procalcitonin (PCT), interleukin-6 (IL-6), lipopolysaccharide binding protein (LBP) levels
and C-reactive protein (CRP) levels, in diﬀerentiating between systemic inﬂammatory response syndrome (SIRS) and sepsis in
critically ill patients. Methods. In this single centre prospective observational study we included all consecutive patients admitted
with SIRS or sepsis to the ICU. Blood samples for measuring CRP, PCT, IL-6 and LBP were taken every day until ICU discharge.
Results. A totalof 76 patients were included, 32 with sepsisand44 with SIRS. Patientswith sepsiswere sickeronadmissionandhad
a higher mortality. CRP, PCT, IL-6 and LBP levels were signiﬁcantlyhigher in patients with sepsis as compared to SIRS. With PCT
levels in the ﬁrst 24 hours after ICU admission<2ng/mL, sepsis was virtually excluded (negative predictive value 97%). With PCT
>10ng/mL, sepsis with bacterial infection was very likely (positive predictive value 88%). PCT was best at discriminating between
SIRS and sepsis with the highest area under the ROC curve (0.95, 95% CI 0.90–0.99). Discussion. This study showed that PCT is
more useful than LBP, CRP and IL-6 in diﬀerentiating sepsis from SIRS.
1.Introduction
Critically, ill patients often present with the systemic inﬂam-
mation syndrome (SIRS), and these patients are treated with
supportive therapy [1]. SIRS is commonly seen after major
surgery, after trauma, with severe inﬂammation as with
pancreatitis and with infection. If SIRS is due to infection,
the diagnosis is sepsis and supportive therapy alone is
insuﬃcient. The diagnosis of sepsis warrants speciﬁc and
rapid therapy including early administration of antibiotics
and control of the source of the sepsis [2]. In addition, sepsis
has a worse prognosis than SIRS. Diﬀerentiating between
sepsis and SIRS is of utmost importance, and this is a
common dilemma for the intensivist. Many biomarkers have
been proposed and tested in a clinical setting, but this search
has not provided a test that is both widely accepted and
enables the bedside clinician to conﬁdently conﬁrm or reject
the diagnosis of sepsis [3]. Serum levels of procalcitonin
(PCT) are elevated in patients with sepsis, and the usefulness
of PCT in diagnosing sepsis has been studied extensively
withconﬂictingresults[4–7].ThebiologicalfunctionofPCT
is not known. Normal serum levels are below 0.5ng/mL,
and patients with levels above 2ng/mL are supposedly at
risk for sepsis [8]. Serum half-time is 24–36 hours. In their
meta-analysis of 33 studies including almost 4000 patients,
Uzzan et al. conclude that PCT is superior to CRP in
diﬀerentiating between sepsis and SIRS and these authors
favour the routine use of PCT to help diﬀerentiate between
SIRS, and sepsis [7]. On the contrary, Tang et al. review
18 studies including 2097 patients to conclude that PCT
cannot reliably diﬀerentiate sepsis from other causes of SIRS
and they argue against the routine use of PCT to aid in
diﬀerentiatingsepsisfromSIRS[6].Interleukin-6(IL-6)isan
important mediator of the acute phase reaction in response
to inﬂammation in sepsis. IL-6 is produced in response to
TNF-alpha stimulation. In the liver, IL-6 induces synthesis
of acute phase proteins like CRP. The normal range of IL-6
serumconcentrationis<5.9pg/mL. Following inﬂammation2 Critical Care Research and Practice
serumlevelsofIL-6havebeenshowntorise withinonehour,
before CRP levels do and even before the onset of fever. IL-6
values above 500pg/mL were found in patients with sepsis
[8]. Lipopolysaccharide binding protein (LBP) is an acute-
phaseprotein producedbytheliverin response tocirculating
bacterial endotoxins or lipopolysaccharide (LPS). LPS is a
constituent of the outer coat of Gram-negative bacteria.
LBP facilitates the binding of LPS to the LPS receptor on
monocytes, resulting in monocyte activation and cytokine
production (e.g., TNF alpha and IL-6). Elevated levels of
serum LBP have been reported in Gram-negative, Gram-
positive, and fungal infections, but not in viral infections
[9]. The normal range of LBP serum concentration is 5 to
10μg/mL [8]. In patients with sepsis LBP levels rise to over
50μg/mL in about 36 hours [8, 10]. CRP is produced by the
liver in response to stimulation by several cytokines one of
which is IL-6 [8]. CRP is measured routinely in hospitalized
patients although it is generally recognized not to be speciﬁc
for sepsis or infection as it is elevated in infectious and
noninfectious states [8, 11]. CRP in itself has pro- and anti-
inﬂammatory properties.
The objective of this prospec t i v es i n g l ec e n t r ec o h o r t
study was to see if PCT, IL-6, and LBP are useful in differ-
entiating between sepsis and SIRS in critically ill patients.
2.Methods
2.1. Study Design and Participants. This single-centre pro-
spective observational study was performed from February
1 through April 30, 2009, in the 10-bed mixed ICU of the
Reinier de Graaf Hospital. The Reinier de Graaf Hospital
is a 500-bed nonacademic teaching hospital. All specialties
except neurosurgery and cardiac surgery are available. The
hospital has an ICU-based medical emergency team. All
consecutive patients admitted to the ICU were included if
they were expected to be treated in the ICU for more than
24hours. Ifa patienthad neither SIRSnorsepsis, this patient
was excluded from the study. If a patient had more than one
ICU episode in the study period, only the ﬁrst episode was
included in the study.
2.2. Sepsis and SIRS. According to the standard deﬁnition
patients with at least two of the following four criteria:
(1) fever (>38◦C)or hypothermia (<36◦C), (2) tachypnoea
(>20/min), (3) tachycardia (>90/min), or (4) leucopenia
(<4.0×109/L), leucocytosis (>12.0×109/L or a leftward shift
(>10% immature granulocytes) were deﬁned as having SIRS
[1]. If SIRS was accompanied with bacterial infection as
proven by cultures or on clinical grounds a patient was
deﬁned as having sepsis [1]. During treatment the doctors in
charge were not blinded but did not use PCT, IL-6, or LBP
results for clinical decision making. The ﬁnal diagnosis of
sepsis or SIRS was made at a later stage from the patients’
records and blinded to PCT, LBP, and IL-6 results. Due to the
small numbers we didnotdiﬀerentiatebetweensepsis, severe
sepsis, or septic shock.
2.3. Data Collection. On admission to the ICU patient char-
acteristicsandillnessseverityscoresweredocumented.Blood
samples for measuring CRP, PCT, IL-6, and LBP were taken
on admission and subsequently at 6 am every morning until
ICU discharge.
2.4. Laboratory Measurements. PCT levels were measured
using a time resolved ampliﬁed cryptate emission (TRACE)
assay (Kryptor Compact; Brahms, Germany). Intra- and
interassay coeﬃcients of variation as determined in our
laboratory were, depending on the sample concentration,
between 2 and 5%. The best cut-oﬀ value of PCT in
discriminating between septic and nonseptic patients is still
unclear, but most authors suggest a cut-oﬀ value of around
2ng/mL. Additionally, we arbitrarily chose a higher cut-oﬀ
value of 10ng/mL to see if we could increase the positive
predictive value of PCT, that is, to ﬁnd a cut-oﬀ value above
which sepsis couldbe conﬁrmed without doubt.LBP and IL-
6 levels were measured using a solid phase, enzyme-labelled
chemiluminescent immunometric assay (IMMULITE 2000;
Siemenshealthcare,TheNetherlands).Interassay coeﬃcients
ofvariationasdeterminedinourlaboratorywere,depending
onthesampleconcentration,between3.9and14.3%forIL-6
andbetween5.9and6.2%forLBP.CRPlevelsweremeasured
using an immunoturbidometric assay (Architect C16000,
Abbott Laboratories). Interassay coeﬃcients of variation, as
determined by the manufacturer, ranged from 0.44% to
1.25%. A cut-oﬀ level of 50mg/L is commonly used clinical
practice.
2.5. Statistical Analysis. For statistical analysis, we used SPSS
1 8 . 0( S P S SI n c . ,C h i c a g o ,I L ) .C o m p a r i s o n sb e t w e e nS I R S
and sepsis patient characteristics were made using the Mann
Whitney U test for continuous variables and Chi square
test for categorical variables. To compare the usefulness of
diﬀerent markers in diagnosing sepsis, we used the highest
value of each marker in the ﬁrst 24 hours of admission
for each patient. Sensitivity, speciﬁcity, positive and negative
predictive values, and diagnostic odds ratios (DOR) were
calculated, and a receiver-operating characteristic (ROC)
curve was made. The DOR can be used to represent test
performance in one single ﬁgure. The DOR is deﬁned
as [sensitivity/(1−sensitivity)]/[(1−speciﬁcity)/speciﬁcity]
and can be read as the ratio of the odds of disease with a
positive test relative to the odds of disease with a negative
t e s t .D O Rc a nr a n g ef r o m0t oi n ﬁ n i t y ,w i t hah i g h e rv a l u e
indicating a better performance of the test. A DOR of 1
means that the test is useless, a DOR > 25 represents a useful
test and a DOR > 100 represent a good test [6, 12, 13].
3.Results
A total of 76 patients were included in the study; 32
with sepsis and 44 with SIRS. Patient characteristics are
summarized in Table 1. As expected, patients with sepsis had
signiﬁcantly higher illness severity scores on admission as
compared to patients with SIRS. Patients with sepsis were
more often ventilated and put on renal replacement therapy.Critical Care Research and Practice 3
Table 1: Patient characteristics.
All Sepsis SIRS P∗∗
Number 76 32 44 —
Age∗ 66 (56–78) 68 (56–78) 65 (54–75) ns
APACHE IV score∗ 57 (44–78) 70 (51–106) 53 (41–63) <.001
APACHE IV exp mort (median) 18% 25% 16% <.001
Medical 35 17 18 —
Planned surgery 25 4 21 .002
Emergency surgery 16 11 5 —
Ventilated 51 24 27 ns
days on ventilator∗ 4 (2–8) 6.5 (3.2–11) 2 (2–6) .018
Renal replacement therapy 10 9 1 .001
Source of sepsis:
gastrointestinal — 17 — —
pulmonary — 8 — —
other — 7 — —
ICU LOS∗∗∗ 3.3 (1.7–7.0) 6.4 (2.4–10.8) 2.7 (1.5–5.8) .024
Hospital LOS∗∗∗ 14 (7–30) 23 (8–36) 12 (7–21) .082
ICU mortality 7 (9%) 5 (16%) 2 (5%) .099
Hospital mortality 14 (18%) 9 (28%) 5 (11%) .063
∗Median, interquartile range.
∗∗For diﬀerence between sepsisand SIRS, Mann Whitney U test for continuous variables and Chi square test for categorical variables.
∗∗∗LOS: length of stay.
Table 2: The highest levels of CRP, PCT, IL-6, and LBP in the ﬁrst 24 hours of ICU treatment.
All Sepsis SIRS P∗∗
CRP∗ (μg/mL) 117 (56–194) 179 (88–297) 80 (52–152) <.001
PCT∗ (ng/mL) 2.2 (0.3–20.3) 24.3 (6.6–57.2) 0.5 (0.2–1.1) <.001
IL-6∗ (pg/mL) 153 (41–750) 1463 (243–12951) 54 (25–149) <.001
LBP∗ (μg/mL) 19.1 (12.6–31.7) 30.9 (14.7–41.5) 16.3 (10.8–22.2) .001
∗Median, interquartile range.
∗∗Mann Whitney U test for diﬀerence between sepsisand SIRS.
Both mortality and length of stay in the ICU were higher in
patients with sepsis.
To compare the usefulness of CRP, PCT, IL-6, and LBP
in diﬀerentiating sepsis from SIRS we used the highest level
of each in the ﬁrst 24 hours of admission. On admission
CRP, PCT, IL-6, and LBP levels were all signiﬁcantly higher
in patients with sepsis in comparison to patients with SIRS
(Table 2). The diﬀerences were not equal: median CRP and
LBPlevelsinsepsis were about 1.5to 2times higherinsepsis,
whereas median PCT and IL-6 were about 10 times higher in
sepsis as compared to SIRS. Interquartile ranges for IL-6 and
PCT did not overlap, but they did overlap for CRP and LBP.
With cut-oﬀ values of 2 and 10ng/mL for PCT, 50μg/mL for
CRP, 50pg/mL for IL-6, and 30μg/mL for LBP sensitivity,
speciﬁcity,andpredictivevaluesarepresentedinTables3and
4. We found that PCT below 2ng/mL makes sepsis highly
unlikely (negative predictive value of 97%) and PCT above
10ng/mL makes sepsis very likely (positive predictive value
88%). PCT has a diagnostic odds ratio of 120.6 with cut-
oﬀ value of 2ng/mL. Figure 1 shows ROC curves and areas
under the curve for CRP, PCT, IL-6, and LBP for diagnosis
of sepsis as opposed to SIRS. The area under the ROC curve
is signiﬁcantly higher for PCT as compared to IL-6, LBP, and
CRP.
In patients with sepsis, maximum values for IL-6 were
reached on day 0, for PCT and CRP on day 1 and for LBP
on day 2 (Figure 2). Il-6 levels in patients with sepsis decline
rapidly after day 1. The diﬀerence in PCT levels between
sepsisandSIRSpatientsismaintainedatleastuntilday3or4.
4.Discussion
This single-centre prospective observational study showed
that serum PCT levels are more valuable than serum CRP,
LBP, and IL-6 levels in discriminating sepsis from SIRS in
criticallyillpatients.PCThas thehighestareaundertheROC
curve and the highest diagnostic odds ratios. If PCT levels in
the ﬁrst 24 hours after ICU admission are below 2ng/mL,
sepsis with bacterial infection is virtually excluded (negative
predictive value 97%). If PCT levels in the ﬁrst 24 hours
after ICU admission are above10ng/mL, sepsis with bacte-
rial infection is very likely (positive predictive value 88%).4 Critical Care Research and Practice
Table 3: Test results using the highest value of the biomarkers within the ﬁrst 24 hours of admissionon the ICU.
Sepsis No sepsis All
CRP (cut-oﬀ value 50μg/mL) Test + 28 34 62
Test − 41 0 1 4
PCT (cut-oﬀ value 2ng/mL) Test + 31 9 40
Test − 13 5 3 6
PCT (cut-oﬀ value 10ng/mL) Test + 21 3 24
Test − 11 41 52
IL-6 (cut-oﬀ value 50pg/mL) Test + 29 26 55
Test − 31 8 2 1
LBP (cut-oﬀ value 30μg/mL) Test + 17 4 21
Test − 15 40 55
All patients 32 44 76
Test +: number of patients with marker-level equal or above cut-oﬀ value.
Test −: number of patients with marker-level below cut-oﬀ value.
Table 4: Sensitivity, speciﬁcity, predictive values, and diagnostic odds ratios using the highest values of all biomarkers within the ﬁrst 24hrs
of ICU admission.
Sensitivity Speciﬁcity PPV NPV DOR (95% CI)
CRP cut-oﬀ value 50μg/mL 88% 23% 45% 71% 2.1 (0.6–7.3)
PCT cut-oﬀ value 2ng/mL 97% 80% 78% 97% 120.6 (14.4–1006)
PCT cut-oﬀ value 10ng/mL 66% 93% 88% 79% 26.1 (6.6–103.8)
IL-6 cut-oﬀ value 50pg/mL 91% 41% 53% 86% 6.7 (1.8–25.4)
LBP cut-oﬀ value 30μg/mL 53% 91% 81% 73% 11.3 (3.3–39.3)
Sensitivity:percentage of septic patients withpositive test.
Speciﬁcity:percentage of nonseptic patients with negative test.
PPV (positive predictive value): percentage of test-positive patientswith sepsis.
NPV (negative predictive value): percentage of test-negative patients without sepsis.
DOR(diagnosticodds ratio):[sensitivity/(1−sensitivity)]/[(1−speciﬁcity)/speciﬁcity]:theratioofthe oddsof diseasewithapositivetestrelative tothe odds
of disease with a negative test.
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Comparing positive and negative predictive values, PCT
seems to be even more useful in excluding sepsis than in
diagnosing sepsis. LBP, CRP, and IL-6 had lower positive and
negative predictive values. IL-6 is the second best after PCT
butthesharp declineofIL-6levelsafteradmission inpatients
with sepsis suggests that late sampling may easily cause false
negative results.
A particular strength of this study it that is compares not
only PCT but also LBP and Il-6 with standard CRP. The fact
that this is a pragmatic real-life study adds to its strength,
but we recognize that this also induces serious limitations.
The study is relatively small, one of the smaller studies on
this subject, and was performed in a single centre where no
cardiac surgery or neurosurgery patients are treated. Also we
found a rather high DOR forPCT (120.6and 26.1 for cut-oﬀ
values of 2 and 10ng/mL, resp.) as compared to the pooled
DOR of 7.79 found by Tang et al. It is quite possible that
due to the limitations of our study we have overestimated
the diagnostic properties of PCT. Although PCT, IL-6, and
LBP values were not used for treatment decisions, treating
physicians were not blinded to the test results and this
may have induced bias. The eventual diagnosis of sepsis
versus SIRS was made by the physicians who were previously
involved in treatment of the patients and this may have
resulted in hindsight bias or information bias. Since patients
with severe sepsis are more likely to be admitted to the ICU
than patients with mild SIRS we may have missed patients
with mild SIRS but with elevated PCT that went unnoticed,
resulting in selection bias.
The real-life value of an additional diagnostic tool is not
easily estimated. The process of reaching a diagnosis is not
entirely rational. In everyday practice clinicians use many
clues (signs, symptoms, epidemiology, experience, etc.) to
reach a (diﬀerential) diagnosis. The value of a test depends
on how probable the clinician thinks a certain diagnosis is
beforehand (pretest probability). If the clinician is not in
doubt any additional test is useless. If the doctor is in doubt
and the additional test brings more certainty on rejecting
or accepting a diagnosis (posttest probability), the test is
useful in this case. In addition, sometimes unlikely options
are taken into account because of the grave consequences of
neglecting suchan option.The inﬂuenceofan additional test
on diagnosis and subsequent action depends not only on the
pretest and posttest probability, but also on our willingness
to act in accordance with the additional test result. In the
contextofthis paper, thiswouldforinstance mean: wouldwe
bewilling towithhold a patientadmitted forsuspected sepsis
antibiotics, if his PCT turned out to be low? The answer
depends on our estimation of the likeliness of sepsis (pretest
probability) but also on our willingness to accept the risk
of not giving antibiotics. The point that we want to make
is that the answer is not purely mathematical and cannot be
given by just studying diagnostic properties of the test. We
would therefore urge clinicians to see for themselves if PCT
could be of value in diﬀerentiating SIRS from sepsis in their
practice, as we have done. Incorporating PCT into clinical
practicecouldimprovedecisionmakingespeciallyinpatients
with conﬂicting clues on the presence or absence of sepsis.
PCT could also be valuable as a means to reduce the length
of antibiotic treatment but that is outside the scope of this
paper [14].
5.Conclusion
Thisstudyshowed thatPCTlevelsareofvalueindiﬀerentiat-
ing between sepsis and SIRSin criticallyill patientsand more
helpful than CRP, IL-6, or LBP levels. Especially during the
ﬁrst 24hourofadmission, PCT levelscan helpdetermine the
course of action to improve outcome, reduce mortality, and
prevent unnecessary diagnostic and therapeutic measures.
Although PCT is the best biomarker to distinguish sepsis
from SIRS its diagnostic properties do not justify clinical
decision making based on PCT alone. The diagnosis of sepsis
still requires integration of multiple clinical data.
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